DiaMedica Therapeutics (NASDAQ:DMAC) Earns “Buy” Rating from HC Wainwright
HC Wainwright reiterated their buy rating on shares of DiaMedica Therapeutics (NASDAQ:DMAC – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $10.00 price objective on the stock. DiaMedica Therapeutics Stock Performance DMAC stock opened at $4.19 on Thursday. The company has a market capitalization of $179.68 million, a […]
HC Wainwright reiterated their buy rating on shares of DiaMedica Therapeutics (NASDAQ:DMAC – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $10.00 price objective on the stock. DiaMedica Therapeutics Stock Performance DMAC stock opened at $4.19 on Thursday. The company has a market capitalization of $179.68 million, a […]
